Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (261-270 of 381) with videos related to

Pageof 39
Sort By:
Translational Andrology and Urology|April 14, 2021
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative reviewAlessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Cancers|November 7, 2020
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and FailuresAlessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, et al.
Expert Review of Anticancer Therapy|February 11, 2025
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated reviewGiulia Claire Giudice, Michele Maffezzoli, Irene Testi, et al.
Expert Opinion on Biological Therapy|November 15, 2024
Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitorsCarmelo Laface, Emanuela Fina, Angela Dalia Ricci, et al.
In Vivo (Athens, Greece)|July 2, 2020
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysisAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
BMC Medical Genetics|November 19, 2020
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial clusterGiovanni Brandi, Alessandro Rizzo, Marzia Deserti, et al.
Cells|September 11, 2020
Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Immunotherapy|April 28, 2021
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Immunotherapy|January 25, 2023
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysisAlessandro Rizzo, Giacomo Nuvola, Gennaro Palmiotti, et al.
Cancers|February 25, 2022
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?Andrea Marchetti, Matteo Rosellini, Giacomo Nuvola, et al.
Pageof 39

Showing results (261-270 of 381) with videos related to

Sort By:
Pageof 39
Translational Andrology and Urology|April 14, 2021
TNM staging towards a personalized approach in metastatic urothelial carcinoma: what will the future be like?-a narrative reviewAlessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Cancers|November 7, 2020
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and FailuresAlessandro Rizzo, Simona Tavolari, Angela Dalia Ricci, et al.
Expert Review of Anticancer Therapy|February 11, 2025
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated reviewGiulia Claire Giudice, Michele Maffezzoli, Irene Testi, et al.
Expert Opinion on Biological Therapy|November 15, 2024
Immunobiology of biliary tract cancer and recent clinical findings in approved and upcoming immune checkpoint inhibitorsCarmelo Laface, Emanuela Fina, Angela Dalia Ricci, et al.
In Vivo (Athens, Greece)|July 2, 2020
How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage in Malignant Obstructive Jaundice: An Updated Systematic Review and Meta-analysisAlessandro Rizzo, Angela Dalia Ricci, Giorgio Frega, et al.
BMC Medical Genetics|November 19, 2020
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial clusterGiovanni Brandi, Alessandro Rizzo, Marzia Deserti, et al.
Cells|September 11, 2020
Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Veronica Mollica, Alessia Cimadamore, et al.
Immunotherapy|April 28, 2021
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Immunotherapy|January 25, 2023
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysisAlessandro Rizzo, Giacomo Nuvola, Gennaro Palmiotti, et al.
Cancers|February 25, 2022
PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?Andrea Marchetti, Matteo Rosellini, Giacomo Nuvola, et al.
Pageof 39